During the past decade, JCRC CRS conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "JCRC CRS" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Dimagi Inc." with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "Janssen Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "JCRC CRS" are "HIV-1 Infection" (2 trials), "HIV Infections" (1 trials) and "Kaposi's Sarcoma" (1 trials). Many other conditions were trialed in "JCRC CRS" in a lesser frequency.

Most popular intervention types in "JCRC CRS" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Darunavir" (1 trials), "Emtricitabine" (1 trials), "Emtricitabine/Tenofovir disoproxil fumarate" (1 trials), "Emtricitabine/tenofovir disoproxil fumarate" (1 trials) and "Etravirine" (1 trials). Other intervention names were less common.

The vast majority of trials in "JCRC CRS" are 3 trials for "All" genders.

Currently, there are NaN active trials in "JCRC CRS". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in JCRC CRS, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in JCRC CRS, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".